Open AccessPrimary Brain Tumors in the Elderly
Author(s) -
Lakshmi Nayak,
Fabio Iwamoto
Publication year - 2010
Publication title -
current neurology and neuroscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.756
H-Index - 72
eISSN - 1534-6293
pISSN - 1528-4042
DOI - 10.1007/s11910-010-0110-x
Subject(s) - medicine , radiation therapy , neurology , neurotoxicity , polypharmacy , brain tumor , chemotherapy , neuroradiology , oncology , asymptomatic , population , pathology , toxicity , psychiatry , environmental health
The incidence of primary brain tumors is highest in elderly patients, and advanced age often is a negative prognostic factor. Nevertheless, large randomized studies in this population are scarce. Elderly patients with primary brain tumors also present unique challenges, such as the presence of multiple comorbidities and polypharmacy, decreased tolerance to chemotherapy, and an increased risk for radiation-induced neurotoxicity. This review gives an overview of the treatment options for older patients with glioblastoma and other gliomas, primary central nervous system lymphomas (PCNSLs), and meningiomas. Selected elderly glioblastoma patients with good performance status may benefit from aggressive treatment with surgical resection, radiotherapy, and possibly chemotherapy. For older patients with PCNSLs, high-dose methotrexate-based chemotherapy should be the mainstay option; whole-brain radiation therapy should be avoided in chemosensitive tumors because of the high risk of irreversible and progressive neurotoxicity. Meningiomas often may be followed up in elderly patients, as they usually are asymptomatic and have a slow growth rate. Treatment for elderly patients with primary brain tumors should be individualized, and age alone should not preclude the use of more aggressive treatments.